Clinical Trial Update: Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating tirzepatide for obesity in postmenopausal hormone receptor-positive breast cancer survivors; the study is not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Obesity

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Obesity (Disorder), Breast Cancer | Phase 4 | Status: NOT_YET_RECRUITING